Park Place Capital’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
Park Place Capital's VRTX Position: Q2 2026 in Review
Park Place Capital increased its Vertex Pharmaceuticals (VRTX) stake by 0.15% in Q2 2026, buying an estimated $443 and bringing the position to 676 shares worth $336K. The position accounts for 0.05% of the portfolio, ranked #186.
Park Place Capital first reported a position in VRTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $606K in Q4 2022. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.
- Park Place Capital held 676 shares of Vertex Pharmaceuticals worth $336K as of Q2 2026.
- Park Place Capital bought 1 Vertex Pharmaceuticals share in Q2 2026, an estimated $443.
- Vertex Pharmaceuticals made up 0.05% of Park Place Capital's portfolio in Q2 2026, its #186 holding.
- Park Place Capital first reported a position in Vertex Pharmaceuticals in Q4 2022 and has held it in 15 quarters since.
- Park Place Capital's Vertex Pharmaceuticals position peaked at $606K in Q4 2022.
- 1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.
Based on Park Place Capital's 13F filing for Q2 2026, filed 14 Aug 2026.